We are live on ! Find out more
RGC

Roberts, Glore & Co Portfolio holdings

AUM $364M
1-Year Est. Return 19.54%
This Fund
S&P 500
This Quarter Est. Return
-0.76%
1 Year Est. Return
+19.54%
3 Year Est. Return
+59.43%
5 Year Est. Return
+77.93%
10 Year Est. Return
+273.65%
AUM
$364M
AUM Growth
-$11.4M
Cap. Flow
-$2.9M
Cap. Flow %
-0.8%
Top 10 Hldgs %
35.18%
Holding
236
New
13
Increased
55
Reduced
116
Closed
20

Sector Composition

1 Technology 17.11%
2 Healthcare 14.76%
3 Financials 11.55%
4 Industrials 9.3%
5 Communication Services 8.05%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
TER icon
101
Teradyne
TER
$50.5B
$768K 0.21%
2,590
-990
-28% -$276K
EBAY icon
102
eBay
EBAY
$49.2B
$761K 0.21%
8,359
-57
-0.7% -$5.12K
ADP icon
103
Automatic Data Processing
ADP
$103B
$753K 0.21%
3,706
SO icon
104
Southern Company
SO
$108B
$746K 0.2%
7,727
-250
-3% -$23.1K
CNI icon
105
Canadian National Railway
CNI
$77.8B
$736K 0.2%
7,166
-67
-0.9% -$6.91K
MRK icon
106
Merck
MRK
$315B
$729K 0.2%
6,059
+1,297
+27% +$150K
CARR icon
107
Carrier Global
CARR
$57.6B
$728K 0.2%
12,937
-1,940
-13% -$115K
LOW icon
108
Lowe's Companies
LOW
$121B
$720K 0.2%
3,049
-30
-1% -$7.82K
CVX icon
109
Chevron
CVX
$366B
$702K 0.19%
3,394
-191
-5% -$34.8K
STT icon
110
State Street
STT
$51.4B
$702K 0.19%
5,544
-266
-5% -$34K
PSX icon
111
Phillips 66
PSX
$80.7B
$693K 0.19%
3,806
-34
-0.9% -$5.33K
BLK icon
112
Blackrock
BLK
$168B
$692K 0.19%
720
-6
-0.8% -$6.31K
EXPE icon
113
Expedia Group
EXPE
$32.5B
$688K 0.19%
2,978
-20
-0.7% -$4.91K
NOC icon
114
Northrop Grumman
NOC
$73.7B
$652K 0.18%
955
-110
-10% -$76.1K
DUK icon
115
Duke Energy
DUK
$98.3B
$631K 0.17%
4,817
+1
+0% +$125
ZBH icon
116
Zimmer Biomet
ZBH
$18.1B
$615K 0.17%
6,797
-568
-8% -$52.1K
CRM icon
117
Salesforce
CRM
$141B
$614K 0.17%
3,288
+641
+24% +$133K
EEM icon
118
iShares MSCI Emerging Markets ETF
EEM
$28B
$608K 0.17%
+10,713
New +$630K
MDT icon
119
Medtronic
MDT
$107B
$606K 0.17%
6,997
+834
+14% +$79.9K
ELV icon
120
Elevance Health
ELV
$80.9B
$603K 0.17%
2,059
+10
+0.5% +$3.29K
NEM icon
121
Newmont
NEM
$97B
$588K 0.16%
5,429
-940
-15% -$108K
BIIB icon
122
Biogen
BIIB
$30.8B
$550K 0.15%
3,001
-80
-3% -$14.7K
MTZ icon
123
MasTec
MTZ
$26.9B
$549K 0.15%
1,705
-105
-6% -$28.4K
GE icon
124
GE Aerospace
GE
$361B
$547K 0.15%
1,926
LLY icon
125
Eli Lilly
LLY
$1.04T
$545K 0.15%
592
-1
-0.2% -$1.01K

Similar funds

Roberts, Glore & Co's Q1 2026 Portfolio in Review

As of Q1 2026, Roberts, Glore & Co held 236 positions worth $364M, down 3% from $375M the previous quarter. Its ten largest holdings account for 35% of the portfolio.

Roberts, Glore & Co's Q1 2026 filing shows 13 new, 55 increased, 116 reduced and 20 closed positions. Its largest new stake was iShares MSCI Emerging Markets ETF: 10,713 shares worth $608K. The largest sale was Gartner, an estimated $963K.

By sector, the portfolio is most concentrated in Technology at 17% of assets, down from 19% a quarter earlier, followed by Healthcare and Financials.

  • Roberts, Glore & Co's largest Q1 2026 buy was iShares MSCI Emerging Markets ETF: 10,713 shares worth $608K.
  • Roberts, Glore & Co added most to Vanguard 0-3 Month Treasury Bill ETF in Q1 2026, an estimated $1.32M increase.
  • Roberts, Glore & Co's biggest Q1 2026 reduction was Alphabet (Google) Class C, cutting an estimated $962K.
  • Roberts, Glore & Co fully exited Gartner in Q1 2026, selling an estimated $963K.
  • Roberts, Glore & Co's ten largest holdings make up 35% of its $364M portfolio in Q1 2026.
  • Roberts, Glore & Co opened 13 new positions and closed 20 in Q1 2026.
  • Roberts, Glore & Co's portfolio value fell 3% quarter-over-quarter to $364M.

Based on Roberts, Glore & Co's 13F filing for Q1 2026, filed 4 May 2026.